Asia Global Research Co.,Ltd.

Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. We partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies in the world to advance healthcare and wellness in the communities we serve.

Accelerated Enrollment Solutions (AES) helps biopharmaceutical companies overcome patient recruitment and research site challenges to deliver greater speed, certainty, and control to clinical trial delivery.

Through the combination of a powerful patient recruiting solution and more than 160 owned and partnered clinical research sites throughout the world, AES provides a single global source for clinical trial sites and patients that delivers centralized control, consistent operations and quality worldwide, and more patients from fewer sites in less time.

AES is a business of PPD, a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services.

For more information, visit www.globalAES.com.

Accell Clinical Research is an international full-service Contract Research Organization (CRO) managing Phase I-III clinical trials for 10+ years across Eastern Europe. With local presence, including highly qualified medical staff and legal entities in the region, we successfully recruit patients both in EU and outside EU in post-Soviet countries (CIS). All together we provide guaranteed fast patient recruitment in 20+ countries across the region.

⬇︎ ACCELL'S SERVICES for Phase I-III clinical trials:

• Strategic guidance and trial set-up:
• Feasibility research and site selection
• Study documentation development
• Regulatory support
• Clinical supply import and management
• Selection and management of clinical study vendors
• Project management
• Clinical & medical monitoring
• Data management and biostatistics
• Quality assurance
• Safety management
• TMF/eTMF services
• Functional outsourcing of a clinical team

⬇︎ THERAPEUTIC AREAS
• Oncology
• Cardiovascular
• Immunology
• Gastroenterology
• Neurology
• Endocrinology

ACIES BIO is a biotechnology contract research organization offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries. We provide full support from idea conceptualization through research to product development. Combining biotechnology and synthetic organic chemistry expertise, we offer a comprehensive service, covering all key development steps for efficient production of biosynthetic natural products or their semi-synthetic derivatives, as well as entirely synthetic compounds.

Working with some of the largest international companies, we provide to our clients full R&D support both in our laboratories as well as on-site at the client’s facilities.

With experience and know-how in natural product (bio)synthesis, milestone-based approach to projects, innovativeness and flexibility, as well as competitive pricing, ACIES BIO aims to become the premier partner in R&D outsourcing for pharmaceutical companies.

Our vision is to conduct clinical trials better and more cost effectively than anyone else. We accomplish this by working with our clients to not only deliver the clinical trial effectively, on time and within budget, but also by leveraging our in-depth expertise to ensure the clinical trial is properly designed.

We believe there is increasing need for innovation, creativity and scientific expertise in clinical research, characteristics often synonymous with small Biopharma and hence, though we are proud to have a number of the world’s largest pharmaceutical companies as our clients, greater than 80% of our client portfolio is small Biopharma.

ACLIRES has performed trials for an international array of biotech companies as well as for some of the largest global pharmaceutical companies. With our broad access to patients and expertise, our aim is to rapidly initiate our client’s studies, even when a very special patient population is required.

Our services include:
- Early Phase Studies
- Late Phase Studies
- Recruitment
- Regulatory Affairs
- Monitoring
- Site Selection
- Scientific Services/Medical Writing
- Consulting
- Quality Management